Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RHONE-POULENC's ACQUISITION OF FRENCH NONPRESCRIPTION DRUG DISTRIBUTOR

This article was originally published in The Tan Sheet

Executive Summary

RHONE-POULENC's ACQUISITION OF FRENCH NONPRESCRIPTION DRUG DISTRIBUTOR Cooperation Pharmaceutique Francaise (Cooper) was approved by both companies' boards of directors on Feb. 24. Cooper announced in a same-day press release that it is encouraging its shareholders to tender their shares to Rhone-Poulenc S.A. by the end of March. The offer values Cooper at between FFr 2.8 bil. and FFr 3 bil., or approximately $500 mil. (based on an exchange rate of $1 = FFr 5.84).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082517

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel